Weight gain and propranolol
Pro Research Analysisby 
Searched over 200M research papers
Weight Gain and Propranolol: An Overview
Long-Term Propranolol Treatment and Weight Gain
Propranolol, a non-selective beta-blocker, has been associated with weight gain in patients undergoing long-term treatment. A retrospective analysis of the Beta Blocker Heart Attack Trial, which included 3,837 men and women treated with propranolol or placebo for up to 40 months, revealed that patients on propranolol experienced a significant weight gain compared to those on placebo. Specifically, at the first annual visit, the mean weight gain for propranolol-treated patients was 2.3 kg, compared to 1.2 kg for the placebo group, with this difference persisting over subsequent annual visits . This weight gain was consistent across different ages and sexes and was not attributable to differences in diuretic use or physical activity levels .
Short-Term Propranolol Use and Rapid Weight Gain
Interestingly, even short-term use of propranolol can lead to significant weight gain. A case study involving a 34-year-old woman treated with low-dose propranolol (20 mg twice daily) for akathisia and tremor reported a rapid weight gain of 3 kg within two weeks. The patient experienced uncontrollable overeating, which ceased upon discontinuation of the drug, suggesting that propranolol may influence appetite and metabolism in unique ways .
Mechanisms Behind Propranolol-Induced Weight Gain
The mechanisms by which propranolol induces weight gain are multifaceted. Research on rats has shown that propranolol treatment can lead to increased insulin levels, higher blood glucose and free fatty acids, and reduced muscle glycogen, indicating a potential for insulin resistance and altered lipid metabolism . Additionally, propranolol-treated rats exhibited a significant reduction in the incorporation of fatty acids into adipose tissues, suggesting a disruption in normal fat metabolism .
Propranolol and Weight Gain in Special Populations
In patients with chronic liver disease, propranolol treatment was associated with a significant increase in body weight, skinfold thickness, and body fat over a 12-month period. These patients also showed favorable changes in salt and water homeostasis, such as a decrease in total body water and an increase in urinary sodium concentration . This indicates that propranolol's effects on weight may be influenced by its impact on fluid balance and metabolism in specific patient populations.
Weight Gain in Migraine Prophylaxis
Propranolol is also used for migraine prevention, and weight gain is a noted side effect. A review of clinical studies on migraine-preventive medications found that propranolol, along with other drugs like amitriptyline and divalproex sodium, is associated with varying degrees of weight gain. This weight gain can be a concern for migraine patients, as it may exacerbate the frequency and severity of migraine attacks .
Conclusion
Propranolol, whether used for cardiovascular conditions, psychiatric symptoms, or migraine prevention, has been consistently linked to weight gain. This effect appears to be dose-dependent and can occur both in the short and long term. The underlying mechanisms may involve changes in appetite, metabolism, and fluid balance. Patients and healthcare providers should be aware of this potential side effect and monitor weight changes during propranolol therapy.
Sources and full results
Most relevant research papers on this topic